ImmunityBio, Inc.
IBRX
$2.84
$0.176.37%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -58.89% | 14.91% | -40.19% | 27.85% | -36.02% |
| Total Receivables | 557.86% | -45.90% | 138.06% | -3.60% | -32.54% |
| Inventory | 2.08% | 322.47% | 8.12% | -- | -- |
| Prepaid Expenses | -18.59% | 10.01% | 34.25% | 0.52% | -19.39% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 13.12% | -33.54% | 10.98% | -18.35% | 12.86% |
| Total Current Assets | -40.86% | 13.14% | -32.81% | 24.07% | -33.45% |
|
|
|||||
| Total Current Assets | -40.86% | 13.14% | -32.81% | 24.07% | -33.45% |
| Net Property, Plant & Equipment | -2.00% | -2.17% | -0.89% | -1.66% | -2.15% |
| Long-term Investments | 0.00% | 0.00% | -- | -- | -- |
| Goodwill | 0.00% | 0.00% | -- | -- | -- |
| Total Other Intangibles | -3.26% | -3.51% | -3.05% | -3.10% | -3.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.63% | 11.64% | 11.04% | 0.12% | -0.70% |
| Total Assets | -20.68% | 5.04% | -17.95% | 10.89% | -20.57% |
|
|
|||||
| Total Accounts Payable | 100.76% | -32.38% | -51.05% | 46.49% | 50.83% |
| Total Accrued Expenses | -32.50% | -4.52% | 17.20% | 10.42% | -22.39% |
| Short-term Debt | -- | -42.30% | -- | -- | -59.59% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.08% | 6.16% | 12.15% | 2.38% | 15.39% |
| Total Finance Division Other Current Liabilities | 66.21% | -24.48% | 28.63% | -33.88% | -10.31% |
| Total Other Current Liabilities | 66.21% | -24.48% | 28.63% | -33.88% | -10.31% |
| Total Current Liabilities | -10.45% | -9.87% | -1.85% | 15.53% | -7.76% |
|
|
|||||
| Total Current Liabilities | -10.45% | -9.87% | -1.85% | 15.53% | -7.76% |
| Long-Term Debt | 4.79% | -23.28% | 1.73% | 12.43% | 1.62% |
| Short-term Debt | -- | -42.30% | -- | -- | -59.59% |
| Capital Leases | -4.96% | -5.27% | 0.92% | -4.64% | -4.36% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -14.51% | -8.43% | -56.00% | -41.75% | -3.87% |
| Total Liabilities | 2.66% | -21.44% | -2.89% | 4.58% | 0.12% |
|
|
|||||
| Common Stock & APIC | 0.30% | 12.22% | 1.53% | 5.33% | 1.23% |
| Retained Earnings | -3.84% | -1.78% | -2.65% | -4.35% | -4.53% |
| Treasury Stock & Other | 1,565.78% | 1,063.11% | 1,387.50% | -14.29% | -170.00% |
| Total Common Equity | -20.92% | 34.36% | -6.70% | -0.92% | -17.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -20.92% | 34.36% | -6.70% | -0.92% | -17.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -2.06% | -1.72% | -2.28% | -1.94% | -2.00% |
| Total Equity | -20.97% | 34.41% | -6.71% | -0.93% | -17.93% |
|
|
|||||